wsava
vaccin
guidelin
group
vgg
conven
respons
produc
global
vaccin
guidelin
dog
cat
would
consid
intern
differ
econom
societ
factor
impact
keep
small
companion
anim
launch
wsava
congress
contemporan
publish
journal
small
anim
practic
day
et
al
english
spanish
version
made
publicli
avail
wsava
websit
recognit
rapidli
develop
field
companion
anim
medicin
vgg
reconven
target
updat
guidelin
veterinarian
prepar
new
set
guidelin
direct
owner
breeder
dog
cat
vgg
met
three
occas
activ
electron
commun
meet
present
document
repres
conclus
first
target
vgg
well
progress
toward
launch
ownerbreed
guidelin
first
activ
second
phase
vgg
assess
impact
guidelin
intern
veterinari
commun
achiev
goal
develop
simpl
questionnair
circul
wsava
member
countri
wsava
assembl
repres
follow
question
ask
guidelin
wide
avail
veterinarian
countri
guidelin
discuss
nation
small
anim
veterinari
associ
nation
small
anim
veterinari
associ
guidelin
vaccin
dog
cat
nation
small
anim
veterinari
associ
adopt
wsava
guidelin
signific
conflict
wsava
guidelin
nation
practic
companion
anim
medic
care
countri
vaccin
guidelin
also
ask
send
copi
vgg
respons
receiv
countri
develop
develop
nation
guidelin
gener
access
veterinari
commun
respond
case
reason
often
unavail
translat
version
notabl
lack
comput
internet
access
gener
practic
also
flag
develop
nation
guidelin
discuss
small
anim
veterinari
associ
respond
countri
thirteen
respond
countri
alreadi
nation
guidelin
place
case
smaller
european
countri
adopt
use
larger
neighbour
vgg
privileg
abl
assess
six
nation
guidelin
document
rang
excel
succinct
summari
detail
substanti
paper
provid
solid
background
discuss
immunolog
vaccin
vgg
pleas
note
countri
without
vaccin
guidelin
nation
organ
either
fulli
adopt
recommend
wsava
guidelin
current
use
develop
nation
recommend
also
clear
countri
public
guidelin
precipit
discuss
nation
organ
sometim
driven
pressur
gener
public
respond
indic
rang
minor
conflict
wsava
guidelin
nation
practic
great
anticip
exampl
mani
countri
maintain
legal
annual
revaccin
rabi
countri
access
full
rang
product
list
guidelin
eg
individu
compon
product
extend
doi
product
other
specif
nation
product
local
manufactur
global
avail
respons
questionnair
underlin
import
global
vaccin
guidelin
current
revis
aim
document
updat
extend
inform
given
version
much
text
recommend
remain
specif
chang
updat
crossprotect
canin
parvoviru
cpv
new
fact
sheet
rabi
vaccin
expand
list
frequent
ask
question
faq
feedback
suggest
aspect
guidelin
document
particularli
use
practition
imag
bank
major
canin
felin
vaccineprevent
diseas
vgg
believ
imag
great
valu
practic
veterinarian
vaccin
interview
client
imag
freeli
avail
via
wsava
websit
provid
visual
evid
signific
sever
infecti
diseas
may
prevent
vaccin
imag
may
use
consult
room
whilst
address
riskbenefit
vaccin
pet
owner
vgg
acknowledg
import
work
undertaken
american
anim
hospit
associ
aaha
canin
vaccin
task
forc
paul
et
al
american
associ
felin
practition
aafp
felin
vaccin
advisori
panel
richard
et
al
address
companion
anim
vaccin
issu
sinc
public
wsava
guidelin
european
advisori
board
cat
diseas
abcd
also
formul
recommend
felin
vaccin
european
perspect
work
group
recent
cumul
public
special
issu
journal
felin
medicin
surgeri
horzinek
thiri
speak
practition
audienc
guidelin
clear
widespread
confus
purpos
mani
practition
initi
alarm
recommend
appear
contrari
given
product
data
sheet
therefor
feel
adopt
guidelin
recommend
leav
open
litig
distinct
differ
data
sheet
guidelin
document
clearli
discuss
recent
paper
thiri
horzinek
data
sheet
summari
product
characterist
spc
legal
document
form
part
registr
process
vaccin
data
sheet
give
detail
qualiti
safeti
efficaci
product
case
vaccin
describ
legal
doi
product
legal
doi
base
experiment
evid
repres
minimum
valu
need
reflect
true
doi
vaccin
companion
anim
vaccin
recent
year
doi
carri
recommend
annual
revaccin
sensibl
respons
industri
recent
discuss
vaccin
safeti
increasingli
licens
product
extend
gener
year
doi
howev
core
vaccin
see
true
doi
like
consider
longer
instanc
guidelin
may
recommend
triennial
vaccin
product
still
carri
year
licens
doi
simpl
reason
guidelin
base
current
scientif
knowledg
think
wherea
data
sheet
reflect
knowledg
avail
time
vaccin
receiv
origin
licens
may
year
earlier
consequ
guidelin
advic
often
differ
given
data
sheet
howev
veterinarian
may
use
vaccin
accord
guidelin
therefor
current
scientif
think
obtain
inform
document
owner
consent
deviat
legal
recommend
offlabel
use
confus
often
caus
compani
repres
advis
legal
oblig
veterinarian
must
adher
data
sheet
recommend
point
confus
aris
veterinarian
compar
recommend
given
differ
set
guidelin
exampl
subtl
differ
recommend
made
usa
europ
reflect
differ
opinion
local
expert
group
percept
lifestyl
pet
anim
may
make
less
expos
infect
vgg
face
difficult
challeng
set
middlecours
variou
nation
region
guidelin
recommend
attempt
provid
balanc
perspect
account
global
differ
keep
small
companion
anim
summari
veterinarian
feel
comfort
vaccin
accord
schedul
given
guidelin
crossrefer
local
recommend
avail
vgg
recommend
differ
current
legal
requir
practition
need
obtain
inform
client
consent
provid
client
anim
current
evidencebas
vaccin
schedul
vaccin
success
necessari
continu
reevalu
vaccin
practic
littl
doubt
develop
countri
major
infecti
diseas
dog
cat
consid
best
uncommon
pet
popul
remain
geograph
pocket
infect
sporad
outbreak
diseas
occur
situat
regard
feral
shelter
popul
distinctli
differ
own
pet
anim
howev
mani
develop
countri
key
infecti
diseas
remain
common
develop
nation
major
caus
mortal
small
anim
although
difficult
obtain
accur
figur
even
develop
countri
estim
pet
anim
popul
vaccin
significantli
less
develop
nation
small
anim
medicin
slow
grasp
concept
herd
immunitythat
vaccin
individu
pet
anim
import
protect
individu
reduc
number
suscept
anim
region
popul
thu
preval
diseas
herd
immun
core
vaccin
provid
long
mani
year
doi
highli
depend
percentag
anim
popul
vaccin
number
vaccin
occur
annual
therefor
everi
effort
made
vaccin
higher
percentag
cat
dog
core
vaccin
second
major
concept
regard
vaccin
dog
cat
recognit
aim
reduc
vaccin
load
individu
anim
order
minim
potenti
advers
reaction
vaccin
product
reason
seen
develop
vaccin
guidelin
base
ration
analysi
vaccin
requir
pet
propos
vaccin
consid
core
noncor
natur
extent
categor
product
base
avail
scientif
evid
person
experi
concert
effort
introduc
effect
companion
anim
diseas
surveil
global
scale
would
provid
definit
basi
recommend
vaccin
usag
parallel
categor
vaccin
push
toward
market
product
extend
doi
reduc
unnecessari
administr
vaccin
therebi
improv
vaccin
safeti
chang
necessit
frameshift
mindset
veterinari
practition
cultur
veterinarian
client
becom
subservi
mantra
annual
vaccin
follow
vgg
guidelin
prepar
consid
optimum
model
commit
pet
owner
will
abl
bring
anim
veterinarian
full
recommend
cours
vaccin
vgg
awar
less
commit
pet
owner
countri
sever
financi
societ
constraint
determin
natur
vaccin
cours
administ
situat
exampl
decis
must
made
individu
pet
may
receiv
singl
core
vaccin
lifetim
vgg
would
emphas
optim
given
time
anim
capabl
respond
immunolog
ie
age
week
greater
vgg
addit
consid
vaccin
shelter
situat
guidelin
propos
consid
provid
optimum
level
protect
highli
suscept
anim
vgg
also
recogn
mani
shelter
run
limit
financi
support
may
constrain
extent
vaccin
use
minimum
vaccin
protocol
situat
would
singl
administr
core
vaccin
time
admiss
shelter
document
seek
address
current
issu
canin
felin
vaccinolog
suggest
practic
measur
veterinari
profess
may
move
toward
ration
use
vaccin
speci
import
messag
vgg
therefor
encapsul
follow
statement
aim
vaccin
everi
anim
core
vaccin
vaccin
individu
less
frequent
give
noncor
vaccin
necessari
anim
basic
immun
schedul
guidelin
recommend
core
recommend
noncor
option
recommend
vaccin
gener
veterinari
practic
given
tabl
vgg
consid
core
vaccin
one
puppi
throughout
world
must
receiv
order
provid
protect
infecti
diseas
global
signific
vgg
recogn
particular
countri
identifi
addit
vaccin
consid
core
particular
exampl
vaccin
may
consid
core
countri
rabi
viru
geograph
area
infect
endem
dog
routin
vaccin
protect
pet
human
popul
countri
mandatori
rabi
vaccin
legal
requir
gener
also
requir
intern
pet
travel
noncor
vaccin
licens
dog
whose
use
determin
basi
anim
geograph
lifestyl
exposur
assess
riskbenefit
ratio
recommend
vaccin
littl
scientif
justif
use
pup
protect
mda
first
week
life
gener
passiv
immun
wane
week
age
level
allow
activ
immun
pup
poor
mda
may
vulner
capabl
respond
vaccin
earlier
age
other
may
possess
mda
high
titr
incap
respond
vaccin
week
age
singl
primari
vaccin
polici
therefor
cover
possibl
situat
recommend
vgg
initi
vaccin
week
age
follow
second
vaccin
week
later
third
vaccin
given
week
age
contrast
present
mani
vaccin
data
sheet
recommend
initi
cours
two
inject
product
also
licens
week
finish
design
second
two
vaccin
given
week
age
rational
behind
protocol
permit
earli
social
pup
vgg
recogn
great
benefit
behaviour
develop
dog
protocol
adopt
great
caution
still
maintain
owner
allow
restrict
exposur
pup
control
area
pup
healthi
fulli
vaccin
vgg
recommend
whenev
possibl
third
dose
core
vaccin
given
week
age
immunolog
term
repeat
inject
given
pup
first
year
life
constitut
booster
rather
attempt
induc
primari
immun
respons
inject
attenu
viru
modifi
live
viru
mlv
vaccin
anim
devoid
neutral
antibodi
must
multipli
process
antigen
present
cell
stimul
antigenspecif
b
lymphocyt
case
kill
inactiv
vaccin
mda
may
also
interfer
immunolog
process
bind
mask
relev
antigen
repeat
dose
requir
dog
receiv
first
booster
month
complet
primari
vaccin
cours
vgg
redefin
basic
immun
protocol
ensembl
pup
regim
plu
first
booster
month
booster
also
ensur
immun
dog
may
adequ
respond
pup
vaccin
dog
respond
vaccin
mlv
core
vaccin
maintain
solid
immun
immunolog
memori
mani
year
absenc
repeat
vaccin
follow
month
booster
subsequ
revaccin
given
interv
year
longer
unless
special
condit
appli
emphas
consider
given
gener
appli
kill
core
vaccin
option
vaccin
particularli
vaccin
contain
bacteri
antigen
thu
leptospira
bordetella
borrelia
lyme
diseas
product
also
parainfluenza
viru
compon
requir
frequent
booster
reliabl
protect
therefor
adult
dog
may
today
still
revaccin
annual
compon
vaccin
may
differ
year
typic
core
vaccin
current
administ
triennial
chosen
noncor
product
given
annual
vgg
awar
countri
multicompon
product
contain
core
noncor
combin
avail
vgg
would
encourag
manufactur
make
full
rang
singlecompon
vaccin
avail
wherev
possibl
adult
dog
receiv
complet
cours
core
vaccin
puppi
follow
month
booster
may
regularli
vaccin
adult
requir
singl
dose
core
vaccin
boost
immun
mani
current
data
sheet
advis
circumst
dog
requir
two
vaccin
puppi
practic
unjustifi
simpli
contrari
fundament
principl
immunolog
memori
contrast
approach
may
justifi
adult
dog
unknown
vaccin
histori
serolog
test
perform
serolog
test
monitor
immun
canin
vaccin
antibodi
test
use
monitor
immun
cdv
rabi
viru
antibodi
assay
cdv
test
greatest
benefit
monitor
immun
especi
puppi
vaccin
seri
recent
year
mani
laboratori
standard
methodolog
test
legal
requir
rabi
antibodi
test
pet
travel
countri
inpractic
test
probabl
becom
popular
soon
rapid
simpl
reliabl
costeffect
assay
wide
avail
neg
test
result
indic
anim
littl
antibodi
revaccin
recommend
dog
fact
immun
falseneg
revaccin
would
unnecessari
posit
test
result
hand
would
lead
conclus
revaccin
requir
robust
yesno
answer
must
provid
assay
cdv
andor
test
anim
neg
result
regardless
test
use
consid
antibodi
suscept
infect
complet
puppi
seri
week
age
anim
posit
test
result
provid
serum
sampl
collect
week
vaccin
seroneg
anim
revaccin
retest
test
neg
consid
nonrespond
possibl
incap
develop
protect
immun
test
antibodi
present
practic
way
ensur
puppi
immun
system
recogn
vaccin
antigen
vaccin
may
fail
variou
reason
mda
neutral
vaccin
viru
common
reason
vaccin
failur
howev
last
vaccin
dose
given
week
age
mda
decreas
low
level
activ
immun
succeed
puppi
vaccin
poorli
immunogen
poor
immunogen
may
reflect
rang
factor
stage
vaccin
manufactur
administr
anim
exampl
viru
strain
passag
histori
product
error
manufactur
particular
batch
product
may
caus
vaccin
failur
postmanufactur
factor
incorrect
storag
transport
interrupt
cold
chain
handl
disinfect
use
vaccin
veterinari
practic
may
result
inactiv
mlv
product
anim
poor
respond
immun
system
intrins
fail
recogn
vaccin
antigen
anim
fail
develop
antibodi
respons
repeat
revaccin
consid
nonrespond
immunolog
nonrespons
genet
control
speci
certain
breed
dog
suspect
poorrespond
believ
unproven
high
suscept
recogn
certain
rottweil
doberman
regardless
vaccin
histori
due
high
preval
nonrespond
usa
today
two
breed
seem
greater
number
nonrespond
breed
possibl
carrier
genet
trait
may
die
infect
dog
breed
may
low
nonrespond
antigen
exampl
uk
germani
nonrespond
phenotyp
preval
amongst
rottweil
rabi
viru
recent
studi
shown
breed
higher
proport
anim
fail
achiev
titr
rabi
antibodi
requir
pet
travel
serolog
test
determin
durat
immun
doi
vaccin
dog
persist
serum
antibodi
core
vaccin
antigen
mani
year
immunolog
antibodi
reflect
function
distinct
popul
longliv
plasma
cell
memori
effector
b
cell
induct
immunolog
memori
primari
object
vaccin
core
vaccin
excel
correl
presenc
antibodi
protect
immun
long
doi
product
correl
exist
mani
noncor
vaccin
doi
relat
product
necessit
frequent
revaccin
interv
antibodi
test
use
demonstr
doi
vaccin
core
vaccin
known
dog
often
maintain
protect
antibodi
cdv
three
year
numer
experiment
studi
support
observ
therefor
antibodi
absent
irrespect
serolog
test
use
dog
revaccin
unless
medic
basi
antibodi
determin
vaccin
compon
limit
valu
short
time
period
antibodi
persist
eg
leptospira
product
lack
correl
serum
antibodi
protect
eg
leptospira
canin
parainfluenza
import
consider
perform
antibodi
test
cost
time
obtain
result
vgg
recogn
present
serolog
test
limit
avail
might
rel
expens
howev
principl
evidencebas
veterinari
medicin
would
dictat
test
antibodi
statu
either
pup
adult
dog
better
practic
simpli
administ
vaccin
booster
basi
safe
cost
less
respons
need
rapid
costeffect
test
develop
vaccin
ie
activ
immun
domin
infecti
diseas
prevent
passiv
immun
also
vener
histori
first
antidiphtheria
serum
hyperimmun
sera
avail
protect
human
infant
anthrax
botul
scarlet
fever
adult
varicellazost
respiratori
syncyti
viru
hepat
b
mump
measl
rabi
although
viru
infect
trigger
cellular
humor
immun
mainli
antibodi
respons
contribut
reduct
viral
load
recoveri
mani
viru
infect
antibodi
level
therefor
taken
correl
protect
viraemia
preexist
inject
antibodi
direct
surfac
structur
virion
latch
particl
neutral
infect
prepar
remov
therapeut
serum
immunoglobulin
prepar
inject
subcutan
quickli
reach
circul
unexpectedli
intraven
infus
plasma
serum
found
work
well
difficult
practic
must
use
caution
local
infect
initi
bite
wound
rabid
carnivor
postexposur
antibodi
prophylaxi
also
proven
invalu
human
rabi
immun
globulin
provid
rapid
protect
given
first
day
postexposur
prophylaxi
regimen
much
possibl
prepar
infiltr
around
wound
may
given
intramuscularli
site
distant
rabi
vaccin
appli
simultan
companion
anim
practic
prevent
activ
immun
commonplac
serum
prophylaxistherapi
consid
except
circumst
eg
dog
present
distemp
cat
present
panleukopenia
diseas
outbreak
kennelcatteri
still
market
serum
immunoglobulin
product
compani
produc
exist
usa
germani
czech
republ
slovakia
russia
brazil
prepar
either
homolog
heterolog
hors
origin
polyval
direct
sever
virus
consist
sera
immunoglobulin
fraction
despit
avail
product
vgg
recommend
use
conserv
care
consider
case
outbreak
cdv
infect
kennel
much
safer
effect
vaccin
dog
cdv
vaccin
rather
give
immun
serum
situat
previous
recommend
mlv
vaccin
administ
intraven
rather
subcutan
intramuscularli
littl
evid
practic
provid
effect
protect
subcutan
inject
administr
cdv
vaccin
rout
provid
protect
sever
diseas
death
immedi
vaccin
instanc
vaccin
prevent
infect
instead
protect
diseas
especi
neurolog
diseas
anim
surviv
subsequ
immun
life
case
catteri
outbreak
fpv
infect
kennel
outbreak
infect
recent
experi
shown
immun
serum
given
clinic
sign
appear
benefit
reduct
morbid
mortal
order
benefici
effect
immun
serum
must
given
infect
prior
onset
clinic
sign
case
administr
immun
serum
must
within
hour
infect
larg
amount
high
titr
serum
requir
serum
must
given
parenter
eg
subcutan
intraperiton
oral
benefit
oral
administr
even
treatment
start
prior
infect
import
consider
shelter
situat
rel
cost
commerci
product
altern
practic
sometim
use
shelter
situat
collect
serum
anim
shelter
surviv
diseas
recent
vaccin
howev
practic
carri
risk
serum
necessarili
screen
transmiss
pathogen
eg
haemoparasit
felin
retrovirus
effect
approach
control
diseas
outbreak
shelter
situat
would
use
serolog
test
determin
serum
antibodi
titr
identifi
anim
protect
therefor
safe
left
shelter
face
diseas
outbreak
anim
suscept
therefor
like
becom
infect
possibl
die
therefor
euthan
suscept
popul
euthan
anim
isol
adopt
foster
certain
infect
new
canin
vaccin
becom
avail
countri
although
scientif
literatur
assess
product
applic
limit
vgg
given
preliminari
consider
emphas
may
fulli
licens
product
limit
region
avail
new
vaccin
canin
influenza
viru
civ
infect
receiv
condit
licens
usa
june
influenza
subtyp
particular
problem
north
america
anim
hous
togeth
date
sporad
case
recogn
elsewher
europ
civ
vaccin
contain
inactiv
viru
administ
pup
week
age
booster
week
later
annual
revaccin
immun
develop
approxim
day
second
dose
vaccin
consid
noncor
recommend
atrisk
dog
like
encount
group
exposur
part
lifestyl
first
canin
immunotherapeut
vaccin
malign
melanoma
receiv
condit
licens
usa
march
fulli
licens
product
compris
human
tyrosinas
gene
incorpor
plasmid
nake
dna
vaccin
repeatedli
deliv
use
highpressur
transderm
inject
devic
vaccin
use
dog
receiv
tradit
treatment
oral
melanoma
induc
immun
respons
melanoma
target
antigen
studi
show
median
surviv
time
dog
grade
iiiv
melanoma
increas
day
expect
surviv
day
bergman
et
al
vaccin
also
recent
becom
avail
europ
usa
limit
use
recogn
veterinari
oncolog
specialist
increas
bodi
scientif
literatur
evalu
first
licens
vaccin
canin
leishmaniosi
product
licens
brazil
leishmaniosi
diseas
major
import
canin
human
popul
activ
programm
cull
seroposit
infect
dog
reduc
reservoir
popul
vaccin
subunit
product
contain
l
donovani
also
known
fucos
mannos
ligand
saponin
adjuv
consid
induc
antibodi
block
transmiss
organ
dog
sand
fli
vector
prevent
bind
leishmania
midgut
sand
fli
vaccin
appear
compat
serolog
test
identifi
infect
dog
vaccin
uninfect
anim
posit
test
use
screen
programm
importantli
larg
scale
epidemiolog
studi
shown
vaccin
addit
effect
cull
programm
region
high
uptak
vaccin
show
reduc
incid
canin
human
infect
palatnik
de
sousa
et
al
find
add
support
concept
vaccin
might
consid
core
countri
brazil
administ
week
age
everi
week
week
age
two
dose
week
apart
gener
recommend
manufactur
one
dose
consid
protect
revaccin
booster
year
annual
cpiv
monoval
combin
noncor
compon
noncor
use
cpiv
mlvintranas
prefer
parenter
product
primari
site
infect
upper
respiratori
tract
administ
earli
week
age
revaccin
within
week
two
dose
week
apart
noncor
product
gener
combin
intranas
bordetella
bronchiseptica
product
administ
annual
follow
puppi
seri
bordetella
bronchiseptica
live
avirul
bacteria
intranas
administ
singl
dose
earli
week
age
best
result
second
dose
given
week
first
singl
dose
annual
often
highrisk
anim
protect
annual
booster
noncor
product
gener
combin
intranas
cpiv
transient
day
cough
sneez
nasal
discharg
may
occur
small
percentag
vaccin
bordetella
bronchiseptica
cell
wall
antigen
extract
parenter
administ
one
dose
week
one
dose
week
age
two
dose
week
apart
annual
often
highrisk
anim
protect
annual
booster
noncor
mlv
intranas
product
prefer
kill
parenter
provid
local
system
protect
recommend
initi
dose
week
age
older
complet
puppi
core
viral
vaccin
second
dose
week
later
two
dose
week
apart
annual
revaccin
prior
start
tick
season
determin
region
noncor
vgg
recommend
vaccin
administ
week
age
prefer
complet
core
seri
puppi
vaccin
gener
recommend
use
dog
known
high
risk
exposur
live
visit
region
risk
vector
tick
exposur
consid
high
diseas
known
endem
leptospira
interrogan
combin
serovar
canicola
icterohaemorrhagia
kill
bacterin
parenter
also
avail
usa
serovar
grippotyphosa
pomona
initi
dose
week
age
older
complet
puppi
core
viral
vaccin
second
dose
week
later
two
dose
week
apart
annual
often
noncor
vaccin
restrict
use
geograph
area
signific
risk
exposur
establish
dog
whose
lifestyl
place
signific
risk
dog
vaccin
week
age
second
dose
week
later
interv
month
risk
reduc
vaccin
one
least
like
provid
adequ
prolong
protect
therefor
must
administ
annual
often
anim
high
risk
protect
infect
differ
serovar
variabl
product
associ
greatest
number
advers
reaction
vaccin
particular
veterinarian
advis
report
acut
anaphylaxi
toy
breed
follow
administr
leptospirosi
vaccin
routin
vaccin
toy
breed
consid
dog
known
high
risk
exposur
cdv
mlv
without
cpiv
rcdv
rcdv
mlv
without
cpiv
combin
product
administ
sq
im
accord
manufactur
recommend
administ
one
dose
prior
immedi
admiss
repeat
week
interv
week
age
anim
still
facil
note
cdv
andor
parvoviru
infect
rate
high
cdv
vaccin
may
administ
earli
week
age
earlier
administ
one
dose
prior
immedi
admiss
repeat
week
ideal
puppi
vaccin
begin
week
age
nurs
histori
alway
avail
face
outbreak
vaccin
earli
week
distemp
parvoviru
may
indic
mda
present
interfer
immun
basic
immun
schedul
guidelin
recommend
core
recommend
noncor
option
recommend
vaccin
gener
veterinari
practic
given
tabl
particular
exampl
vaccin
may
consid
core
countri
rabi
viru
geograph
area
infect
endem
cat
routin
vaccin
protect
pet
human
popul
countri
mandatori
rabi
vaccin
legal
requir
gener
also
requir
intern
pet
travel
term
felin
core
vaccin
import
realiz
protect
afford
fcv
vaccin
provid
efficaci
immun
seen
fpv
vaccin
thu
felin
core
vaccin
expect
give
robust
protect
durat
immun
seen
canin
core
vaccin
although
fcv
vaccin
design
produc
crossprotect
immun
sever
clinic
diseas
multipl
strain
fcv
possibl
infect
mild
diseas
occur
vaccin
anim
respect
rememb
herpesviru
vaccin
protect
infect
virul
viru
virul
viru
becom
latent
may
reactiv
period
sever
stress
reactiv
viru
may
caus
clinic
sign
vaccin
anim
viru
shed
suscept
anim
caus
diseas
vgg
adopt
recommend
triennial
revaccin
fcv
appreci
point
debat
amongst
expert
exampl
abdc
recommend
annual
revaccin
cat
consid
high
risk
triennial
revaccin
low
risk
predominantli
indoor
anim
vaccin
felin
leukaemia
viru
felv
also
often
point
debat
amongst
expert
vgg
regard
felv
noncor
vaccin
tabl
fulli
appreci
use
product
may
determin
lifestyl
perceiv
exposur
risk
individu
cat
preval
infect
local
environ
mani
felin
expert
believ
even
though
preval
felv
infect
markedli
reduc
due
success
vaccin
control
programm
cat
less
year
old
element
outdoor
lifestyl
receiv
benefit
protect
routin
vaccin
dose
vaccin
given
week
apart
start
earlier
week
age
riskbenefit
analysi
felv
form
routin
part
felin
vaccin
interview
intranas
use
parenter
administr
must
avoid
administ
singl
dose
earli
week
age
best
result
administ
prior
week
age
addit
dose
given
week
age
two
dose
week
apart
recommend
intranas
avirul
live
vaccin
prefer
parenter
vaccin
puppi
safe
administ
puppi
younger
week
addit
singl
dose
may
protect
bordetella
bronchiseptica
avail
kill
bacterin
antigen
extract
parenter
administr
administ
one
dose
time
admiss
administ
second
dose
week
later
two
dose
week
apart
recommend
topic
vaccin
adult
dog
puppi
older
week
advantag
provid
nonspecif
immun
immedi
vaccin
wherea
parenter
canin
respiratori
diseas
complex
kennel
cough
vaccineprevent
diseas
vaccin
use
help
manag
diseas
canin
influenza
viru
civ
avail
kill
parenter
vaccin
administ
first
dose
earlier
week
age
follow
week
second
dose
administ
two
dose
week
apart
annual
revaccin
recommend
anim
longstay
shelter
influenza
vaccin
gener
immun
serotypespecif
product
avail
usa
singl
dose
two
dose
week
apart
highli
endem
area
administ
time
discharg
facil
singl
dose
administ
time
discharg
facil
administr
rabi
vaccin
determin
whether
shelter
countri
diseas
endem
local
statut
kitten
vaccin
month
booster
discuss
pup
kitten
protect
mda
first
week
life
howev
without
serolog
test
level
protect
point
kitten
becom
suscept
infect
andor
respond
immunolog
vaccin
unknown
relat
level
matern
antibodi
variat
uptak
mda
litter
gener
mda
wane
week
age
level
allow
activ
immunolog
respons
initi
vaccin
week
age
follow
second
vaccin
week
later
commonli
recommend
mani
vaccin
carri
data
sheet
recommend
effect
howev
kitten
poor
mda
may
vulner
capabl
respond
vaccin
earlier
age
other
may
possess
mda
high
titr
incap
respond
vaccin
sometim
week
age
therefor
vgg
recommend
administr
final
kitten
dose
week
older
kitten
receiv
core
vaccin
minimum
three
dose
one
week
age
second
week
later
final
dose
week
age
older
administ
cat
respond
mlv
core
vaccin
maintain
immun
mani
year
absenc
repeat
vaccin
cat
receiv
first
booster
within
month
complet
kitten
vaccin
cours
ensur
adequ
vaccineinduc
immun
cat
may
adequ
respond
primari
cours
follow
first
booster
subsequ
revaccin
given
interv
year
longer
unless
special
condit
appli
adult
cat
unknown
vaccin
statu
receiv
singl
initi
mlv
core
vaccin
inject
follow
booster
vaccin
year
later
cat
respond
vaccin
mlv
core
vaccin
maintain
solid
immun
immunolog
memori
mani
year
absenc
repeat
vaccin
emphas
consider
given
gener
appli
kill
core
vaccin
option
vaccin
particularli
vaccin
contain
bacteri
antigen
thu
chlamydophila
bordetella
product
requir
annual
booster
limit
protect
afford
product
therefor
adult
cat
may
today
still
receiv
annual
vaccin
howev
compon
vaccin
may
differ
year
typic
core
vaccin
current
administ
triennial
chosen
noncor
product
given
annual
vgg
awar
countri
multicompon
product
contain
core
noncor
combin
avail
vgg
would
encourag
manufactur
make
full
rang
vaccin
avail
wherev
possibl
least
make
core
combin
want
give
noncor
vaccin
adult
cat
receiv
complet
cours
vaccin
fpv
fcv
kitten
includ
month
booster
may
regularli
vaccin
adult
requir
singl
dose
vaccin
boost
immun
note
mani
current
data
sheet
advis
circumst
cat
requir
two
vaccin
kitten
practic
unjustifi
simpli
contrari
fundament
principl
immunolog
memori
contrast
approach
may
justifi
adult
cat
vaccin
histori
unknown
serolog
test
anim
perform
past
year
becom
evid
one
trigger
felin
inject
site
sarcoma
fiss
may
administr
adjuv
felv
rabi
vaccin
subcutan
inject
includ
vaccin
tradit
given
interscapular
region
cat
common
site
format
fiss
infiltr
natur
tumour
meant
often
radic
surgic
resect
necessari
attempt
remov
lesion
north
america
respons
issu
recommend
protocol
wherebi
two
perceiv
highrisk
adjuv
vaccin
would
administ
distinct
anatom
site
would
amen
surgic
remov
fiss
might
develop
accordingli
recommend
left
leg
leukaemia
right
leg
rabi
suggest
felv
vaccin
given
far
distal
possibl
left
hind
limb
whilst
rabi
vaccin
given
far
distal
possibl
right
hind
limb
recent
studi
evalu
effect
practic
compar
anatom
distribut
fiss
cat
recommend
made
practic
adopt
data
show
signific
decreas
preval
interscapular
fiss
increas
preval
tumour
right
left
hind
limb
notabl
also
increas
number
tumour
report
aris
right
left
later
abdomen
attribut
difficultli
inject
distal
hindlimb
abdomin
site
accident
inject
shaw
et
al
practic
adopt
outsid
north
america
given
recent
data
vgg
recommend
follow
approach
reduc
risk
fiss
nonadjuv
vaccin
administ
cat
wherev
possibl
vaccin
particularli
adjuv
product
administ
interscapular
region
vaccin
particularli
adjuv
product
administ
subcutan
intramuscular
site
access
site
accept
safeti
vaccin
ie
avoid
accident
selfinject
difficult
restraint
anim
would
appear
skin
later
thorax
abdomen
skin
later
abdomen
repres
best
choic
fiss
might
aris
site
may
readili
excis
occur
interscapular
intercost
region
extens
surgic
resect
requir
vaccin
administ
differ
site
occas
site
record
patient
record
vaccin
card
use
diagram
indic
product
administ
one
occas
site
rotat
occas
altern
practic
might
develop
group
polici
felin
vaccin
administ
specif
site
one
calendar
year
site
rotat
follow
year
vgg
encourag
case
suspect
fiss
notifi
via
appropri
nation
report
rout
suspect
advers
reaction
point
time
limit
avail
serolog
test
vaccin
antibodi
respons
cat
test
detect
fpv
antibodi
context
still
develop
titr
check
test
routin
use
usa
cpv
antibodi
use
detect
fpv
antibodi
cat
anticip
titr
test
serum
antibodi
fcv
ever
valu
measur
vaccin
immun
cat
therefor
vgg
endors
use
serolog
test
fpv
antibodi
test
result
use
way
describ
dog
emphas
antibodi
test
fiv
use
diagnos
diseas
valu
determin
immun
fiv
administ
initi
dose
earli
week
age
second
dose
administ
week
later
administ
dose
week
apart
annual
booster
indic
cat
sustain
exposur
risk
noncor
vaccin
appropri
use
part
control
regim
cat
multiplecat
environ
infect
associ
clinic
diseas
confirm
inadvert
conjunctiv
inocul
vaccin
report
caus
clinic
sign
infect
vaccin
may
associ
advers
reaction
hypersensit
bordetella
bronchiseptica
avirul
live
nonadjuv
intranas
administ
singl
dose
intranas
earli
week
age
annual
booster
indic
cat
sustain
risk
noncor
vaccin
may
consid
case
cat
like
specif
risk
infect
studi
shown
product
reduc
sever
felin
respiratori
diseas
complex
kill
parenter
giardia
lamblia
vaccin
cat
list
guidelin
longer
avail
singl
dose
administ
time
discharg
facil
singl
dose
administ
time
discharg
facil
administr
rabi
vaccin
determin
whether
shelter
countri
diseas
endem
local
statut
anim
shelter
hold
facil
anim
usual
await
adopt
rescu
reclaim
owner
gener
anim
shelter
character
random
sourc
popul
mostli
unknown
vaccin
histori
high
popul
turnov
high
infecti
diseas
risk
term
shelter
encompass
situat
rang
sanctuari
possess
stabl
popul
facil
admit
hundr
anim
per
day
rescu
foster
home
care
multipl
individu
litter
given
time
vaccin
strategi
vari
individu
pet
onesizefitsal
strategi
vaccin
shelter
anim
likelihood
exposur
potenti
devast
consequ
infect
necessit
clearli
defin
shelter
vaccin
program
shelter
medicin
differ
individu
care
practic
environ
erad
infecti
diseas
attain
possibl
howev
minim
spread
infect
within
highdens
highrisk
popul
maintain
health
yet
infect
individu
overal
purpos
place
healthi
pet
welcom
home
time
effort
dedic
control
infecti
diseas
one
mani
variabl
complex
shelter
medicin
husbandri
equat
recommend
provid
attempt
address
shelteruniqu
issu
pertain
vaccin
diseas
control
guidelin
recommend
vaccin
use
shelter
given
tabl
unambigu
document
vaccin
provid
anim
time
admiss
shelter
reason
revaccin
canin
core
vaccin
felin
core
vaccin
specif
fcv
fhv
may
valu
boost
immun
vgg
discrimin
shelter
board
kennelcatteri
later
facil
fulli
vaccin
anim
may
temporarili
board
rel
short
period
time
eg
owner
vacat
requir
entri
facil
individu
dog
cat
fulli
vaccin
core
product
given
accord
guidelin
present
herein
use
noncor
vaccin
respiratori
infect
also
appropri
circumst
vgg
awar
countri
vaccin
protocol
anim
enter
board
kennelcatteri
formul
local
author
may
contrari
current
guidelin
eg
insist
annual
revaccin
vgg
encourag
author
reconsid
recommend
light
current
scientif
think
past
veterinari
practic
benefit
annual
administr
vaccin
encourag
owner
bring
pet
yearli
vaccin
veterinarian
abl
recogn
treat
diseas
earlier
might
otherwis
case
addit
annual
visit
provid
opportun
inform
client
import
aspect
canin
felin
health
care
unfortun
mani
client
come
believ
vaccin
import
reason
annual
veterinari
visit
veterinarian
concern
reduct
vaccin
frequenc
caus
client
forgo
annual
visit
qualiti
care
diminish
therefor
essenti
veterinarian
stress
import
aspect
comprehens
individu
health
care
program
emphasi
place
detail
vaccin
interview
comprehens
physic
examin
veterinarian
individu
patient
care
import
dental
care
proper
nutrit
appropri
diagnost
test
control
parasit
zoonot
diseas
also
address
evalu
pet
behaviour
concern
discuss
well
necess
frequent
examin
young
geriatr
anim
yearli
health
carevaccin
interview
assess
need
noncor
vaccin
pet
practition
explain
client
type
vaccin
avail
potenti
benefit
risk
applic
particular
anim
given
lifestyl
risk
exposur
whilst
anim
might
receiv
core
vaccin
everi
year
noncor
vaccin
requir
annual
administr
owner
continu
see
anim
vaccin
annual
region
incid
risk
factor
variou
infecti
diseas
also
discuss
way
reduc
impact
acquir
diseas
eg
avoid
overcrowd
improv
nutrit
restrict
access
infect
anim
also
review
vaccin
consid
one
compon
comprehens
prevent
health
care
plan
individu
base
age
breed
health
statu
environ
potenti
exposur
harm
agent
lifestyl
contact
anim
travel
habit
pet
age
signific
effect
prevent
health
care
need
given
individu
puppykitten
program
tradit
focus
vaccin
parasit
control
neuter
today
opportun
exist
incorpor
behaviour
counsel
zoonot
diseas
manag
age
pet
senior
care
program
becom
increasingli
popular
nutrit
dental
diseas
parasit
control
assess
counsel
take
place
individu
basi
throughout
life
pet
evid
older
dog
cat
fulli
vaccin
pup
kitten
requir
special
programm
core
vaccin
experiment
evid
show
age
dog
cat
persist
immunolog
memori
core
vaccin
readili
boost
administr
singl
vaccin
dose
contrast
age
anim
may
effici
mount
primari
immun
respons
novel
antigen
previous
encount
studi
uk
dog
cat
vaccin
first
time
rabi
pet
travel
clearli
shown
age
anim
fail
achiev
legal
requir
antibodi
titr
certain
breed
predispos
variou
diseas
earli
detect
particularli
neoplasia
manag
breedassoci
diseas
significantli
improv
qualiti
anim
entir
life
pet
chronic
medic
condit
warrant
period
schedul
medic
progress
examin
test
anim
receiv
certain
medic
also
warrant
therapeut
monitor
blood
level
andor
organ
system
develop
recheck
protocol
chronic
diseas
medic
includ
remind
system
greatli
improv
client
complianc
accordingli
pet
care
environ
pet
resid
profoundli
affect
health
statu
assess
annual
health
care
visit
order
defin
risk
factor
develop
appropri
prevent
measur
determin
extent
dog
cat
come
contact
anim
unobserv
circumst
veterinarian
assess
need
noncor
vaccin
dog
visit
kennel
groom
salon
common
area
wood
tickinfest
area
potenti
greater
risk
certain
infecti
diseas
dog
frequent
area
human
popul
becom
mobil
pet
popul
result
potenti
exposur
infecti
agent
parasit
environment
hazard
found
home
environ
determin
past
anticip
futur
travel
visit
allow
greater
individu
prevent
care
diagnost
test
plan
time
vaccin
administr
follow
inform
record
patient
perman
medic
record
date
vaccin
administr
ident
name
initi
code
person
administ
vaccin
vaccin
name
lot
serial
number
expiri
date
manufactur
site
rout
vaccin
administr
use
peeloff
vaccin
label
stamp
imprint
medic
record
outlin
pet
facilit
type
record
keep
mandatori
countri
advers
event
record
manner
alert
staff
member
futur
visit
inform
consent
document
medic
record
order
demonstr
relev
inform
provid
client
client
author
procedur
eg
offlabel
use
product
discuss
least
notat
indic
discuss
risk
benefit
took
place
prior
vaccin
advers
event
defin
side
effect
unintend
consequ
includ
lack
protect
associ
administr
vaccin
product
includ
injuri
toxic
hypersensit
reaction
associ
vaccin
whether
event
directli
attribut
vaccin
advers
event
report
whether
associ
vaccin
recogn
suspect
vaccin
advers
event
report
identifi
product
anim
involv
event
individu
submit
report
report
field
observ
unexpect
vaccin
perform
import
mean
manufactur
regulatori
agenc
alert
potenti
vaccin
safeti
efficaci
problem
may
warrant
investig
purpos
prelicensur
safeti
studi
detect
rel
common
advers
event
rare
advers
event
detect
postmarket
surveil
analysi
report
advers
event
advers
event
report
manufactur
andor
local
regulatori
author
mani
countri
government
surveil
scheme
avail
reaction
therefor
notifi
manufactur
vgg
recogn
gross
underreport
vaccineassoci
advers
event
imped
knowledg
ongo
safeti
product
vgg
would
activ
encourag
veterinarian
particip
surveil
scheme
particular
advers
event
well
document
report
serv
provid
baselin
futur
report
compar
addit
report
advers
event
lead
detect
previous
unrecogn
reaction
detect
increas
known
reaction
recognit
risk
factor
associ
reaction
identif
vaccin
lot
unusu
event
higher
number
advers
event
stimul
clinic
epidemiolog
laboratori
studi
therefor
veterinarian
encourag
report
clinic
signific
advers
event
occur
administr
licens
vaccin
report
vaccin
advers
event
indict
particular
vaccin
facilit
review
tempor
associ
condit
add
safeti
databas
product
work
vaccin
guidelin
group
gener
sponsor
intervetsch
plough
wsava
vgg
independ
group
academ
expert
formul
guidelin
without
consult
industri
recent
emerg
genotyp
recogn
north
south
america
europ
asia
genotyp
antigen
compar
vaccin
current
cpv
vaccin
provid
protect
immun
variant
current
vaccin
contain
either
usa
protect
current
circul
variant
includ
kill
vaccin
avail
less
effect
take
much
longer
induc
immun
respons
compar
mlv
vaccin
recommend
routin
use
kill
vaccin
may
provid
benefit
wild
exot
speci
pregnant
bitch
mlv
vaccin
recommend
howev
kill
vaccin
test
safeti
efficaci
situat
doi
natur
infectiondiseas
lifelong
doi
vaccin
mlv
vaccin
year
longer
base
challeng
serolog
studi
doi
vaccin
kill
vaccin
unknown
kill
felin
parvoviru
panleukopenia
vaccin
demonstr
challeng
studi
provid
doi
year
cat
system
immun
vaccin
mlv
product
mediat
igg
igm
neutral
antibodi
antibodi
titr
correl
protect
immun
stimul
multipl
dose
parenter
administ
kill
nonadjuv
vaccin
secretori
iga
cmi
shown
import
protect
immun
mda
interfer
activ
immun
vari
period
time
puppi
depend
titr
colostr
antibodi
amount
antibodi
absorb
birth
well
specif
vaccin
window
suscept
defin
period
time
pup
infect
field
viru
vaccin
immun
highli
effect
mlv
vaccin
window
suscept
short
two
week
less
wherea
less
effect
vaccin
window
suscept
long
week
complet
puppi
seri
around
week
vaccin
year
age
revaccin
need
done
often
everi
year
absenc
mda
mlv
vaccin
provid
immun
earli
day
vaccin
presenc
serum
antibodi
regardless
titr
activ
immun
dog
age
week
correl
protect
geograph
area
isol
facil
endem
domest
wild
suscept
speci
mlv
vaccin
use
viru
shed
could
potenti
revert
virul
well
infect
individu
speci
attenu
vaccin
alway
shed
caus
diseas
incontact
pup
week
age
may
immun
howev
may
caus
problem
eg
myocard
young
less
week
age
antibodi
neg
pup
infectionsdiseas
sign
exot
wild
speci
mlv
shed
low
level
faec
sever
day
vaccin
revers
virul
mlv
vaccin
confirm
case
diseas
caus
vaccin
viru
report
puppi
younger
week
vaccin
mlv
product
dog
found
posit
antigen
test
especi
sign
parvovirosi
regardless
recent
week
vaccin
anim
consid
infect
virul
vaccin
dog
usual
shed
enough
viru
caus
antigen
captur
elisa
test
becom
posit
contrast
pcr
test
perform
faec
posit
day
recent
vaccin
antibodi
neg
dog
infect
take
day
longer
sign
diseas
appear
faecal
shed
rare
persist
week
dog
persist
infect
week
report
one
expect
anim
die
clear
viru
period
time
environ
howev
viru
remain
infecti
one
year
therefor
facil
infect
anim
present
must
consid
infect
fact
sheet
canin
adenoviru
vaccin
contain
vaccin
commonli
avail
product
vaccin
recommend
prevent
infecti
canin
hepat
ich
caus
reduc
sign
respiratori
diseas
associ
infect
except
effect
caus
advers
reaction
commonli
seen
vaccin
known
allerg
uveiti
blue
eye
addit
parenter
mlv
vaccin
prepar
combin
monoval
product
protect
canin
respiratori
diseas
complex
crdc
includ
multipl
bacteria
notabl
bordetella
bronchiseptica
multipl
virus
notabl
canin
parainfluenza
viru
canin
influenza
viru
intranas
product
contain
cpiv
bordetella
use
decreas
sever
crdc
use
vaccin
prevent
ich
purpos
parenter
also
given
inactiv
kill
vaccin
avail
countri
recommend
poorli
effect
caus
advers
reaction
doi
natur
infect
ich
diseas
lifelong
doi
vaccin
mlv
vaccin
year
longer
base
challeng
serolog
studi
doi
protect
ich
kill
unknown
doi
protect
crdc
caus
combin
agent
approxim
year
multifactori
diseas
crdc
vaccineprevent
current
vaccin
help
reduc
diseas
sever
factor
like
stress
poor
ventil
dust
ammonia
ga
unsanitari
facil
infect
streptococcu
spp
pasteurella
multocida
bordetella
bronchiseptica
mycoplasma
spp
cpiv
civ
canin
respiratori
coronaviru
contribut
crdc
system
immun
vaccin
mediat
igg
viru
neutral
antibodi
immun
associ
crdc
mediat
igg
secretori
iga
intranas
vaccin
given
igg
antibodi
develop
parenter
vaccin
protect
lung
infectiondiseas
upper
respiratori
tract
infect
requir
secretori
iga
local
cellmedi
immun
vaccin
may
provid
adequ
protect
ich
anim
receiv
intranas
vaccin
mda
block
immun
vaccin
parenter
product
protect
offer
intranas
product
sinc
protect
ich
afford
primarili
parenter
product
last
dose
given
along
viral
vaccin
eg
cdv
puppi
week
age
older
complet
puppi
seri
around
week
vaccin
year
age
revaccin
need
done
often
everi
year
absenc
mda
mlv
vaccin
protect
ich
earli
day
vaccin
presenc
serum
antibodi
regardless
titr
activ
immun
dog
age
week
correl
protect
given
intranas
readili
shed
respiratori
tract
wherea
shed
given
parenter
vaccin
viru
shown
revert
virul
back
passag
studi
similar
adenovirus
caus
neoplast
transform
variou
cell
type
hamster
kidney
cell
vitro
signific
observ
dog
known
viru
commonli
present
upper
respiratori
tract
dog
thu
natur
immun
especi
among
shelter
show
kennel
dog
widespread
experiment
infect
take
day
longer
sign
ich
appear
combin
agent
associ
crdc
caus
respiratori
diseas
day
transmit
primarili
air
wherea
transmit
primarili
contamin
secret
excret
saliva
urin
moder
stabl
surviv
sever
day
week
environ
common
product
gener
contain
cdv
strain
rockborn
snyder
hill
onderstepoort
lederl
other
variou
titr
mani
biotyp
cdv
caus
vari
clinic
sign
wide
varieti
speci
howev
serolog
differ
among
mani
isol
insignific
vaccin
one
current
vaccin
provid
protect
immun
biotyp
poxviru
recombin
product
avail
usa
countri
safe
effect
often
use
wild
exot
speci
suscept
cdv
infect
diseas
kill
vaccin
readili
avail
effect
therefor
use
immun
distemp
doi
natur
infectiondiseas
lifelong
doi
vaccin
mlv
vaccin
year
longer
base
challeng
serolog
studi
doi
vaccin
rcdv
vaccin
year
base
challeng
year
base
serolog
doi
vaccin
kill
vaccin
unknown
recommend
system
immun
predominantli
mediat
neutral
antibodi
prevent
infect
antibodi
cmi
vaccin
anim
humor
immun
provid
igg
secretori
antibodi
play
littl
role
prevent
infect
vaccin
anim
mda
interfer
activ
immun
vari
period
time
puppi
depend
titr
colostr
antibodi
amount
antibodi
absorb
birth
window
suscept
defin
period
time
pup
infect
field
viru
vaccin
immun
unlik
vaccin
gener
long
window
suscept
cdv
vaccin
less
week
puppi
vaccin
use
mlv
product
start
earlier
week
age
complet
seri
around
week
vaccin
year
age
revaccin
need
done
often
everi
year
absenc
mda
mlv
recombin
vaccin
provid
immun
immedi
vaccin
cdv
vaccin
among
effect
vaccin
compar
vaccin
speci
activ
immun
dog
develop
diseas
regardless
amount
viru
expos
contact
infect
presenc
serum
antibodi
regardless
titr
activ
immun
dog
age
week
correl
protect
mlv
prepar
attenu
modifi
use
domest
dog
use
wild
exot
speci
vaccin
highli
virul
eg
ferret
blackfoot
ferret
grey
fox
caus
diseas
death
vaccin
speci
mlv
vaccin
never
consid
puppi
younger
week
vaccin
mlv
vaccin
young
pup
wild
exot
suscept
speci
rcdv
vector
vaccin
recommend
local
unavail
one
make
everi
attempt
obtain
rcdv
vaccin
rather
use
mlv
product
prepar
contain
ondesterpoort
strain
consid
safest
even
mlv
strain
creat
problem
certain
wildexot
speci
sign
diseas
appear
week
infect
incub
period
cdv
caus
immunosuppress
make
anim
suscept
microbi
infect
may
lead
respiratori
diseas
pneumonia
death
typic
sign
distemp
viru
infect
appear
environ
viru
quickli
loos
infect
prepar
contain
attenu
avirul
felin
parvoviru
felin
panleukopenia
viru
variou
titr
without
adjuv
inject
prepar
other
intranas
applic
combin
vaccin
antigen
eg
fcv
mlv
vaccin
advantag
faster
onset
action
greater
efficaci
overcom
matern
antibodi
greater
likelihood
confer
suffici
immun
intranas
fpv
combin
vaccin
use
shelter
environ
use
immun
given
simultan
mlvfpv
parenter
product
kill
adjuv
fpv
vaccin
avail
singl
inject
dose
product
may
induc
good
antibodi
respons
cat
within
rel
short
time
span
howev
kill
fpv
product
requir
two
dose
week
apart
immun
present
second
dose
kill
vaccin
may
benefici
wild
exot
speci
pregnant
queen
mlv
vaccin
recommend
doi
natur
infectiondiseas
lifelong
doi
vaccin
mlv
vaccin
year
longer
base
challeng
serolog
studi
doi
vaccin
kill
panleukopenia
vaccin
demonstr
last
minimum
year
case
felin
panleukopenia
caus
infect
fpv
variant
canin
parvoviru
emerg
infect
cat
may
caus
diseas
current
fpv
vaccin
afford
protect
cpv
variant
system
immun
vaccin
mediat
neutral
antibodi
antibodi
titr
correl
protect
secretori
iga
cmi
import
protect
immun
immun
occur
earli
day
vaccin
matern
deriv
antibodi
mda
interfer
activ
immun
vari
period
time
kitten
depend
titr
colostr
antibodi
amount
antibodi
absorb
first
hour
birth
window
suscept
defin
period
time
kitten
infect
field
viru
vaccin
immun
analog
canin
parvoviru
immun
gap
assum
exist
around
week
age
antibodi
level
low
protect
natur
infect
still
high
enough
interfer
vaccin
complet
kitten
seri
around
week
vaccin
year
age
revaccin
need
done
often
everi
year
presenc
serum
antibodi
regardless
titr
activ
immun
cat
age
week
correl
protect
concern
rais
regard
revers
virul
mlv
strain
never
document
nevertheless
region
facil
fpv
endem
domest
wild
suscept
speci
mlv
vaccin
use
mlv
fpv
vaccin
never
use
pregnant
queen
risk
transfer
viru
fetu
fetal
damag
countri
inactiv
fpv
vaccin
licens
use
pregnant
queen
gener
unnecessari
administr
product
pregnant
queen
avoid
mlv
fpv
vaccin
never
administ
kitten
less
week
age
avoid
damag
cerebellum
still
develop
neonat
mlv
fpv
vaccin
use
caution
sever
immunosuppress
individu
although
risk
appear
small
sever
immunosuppress
exampl
clinic
fiv
felv
infect
use
highli
immunosuppress
drug
failur
control
viral
replic
could
potenti
lead
clinic
sign
vaccin
vaccin
use
control
diseas
face
outbreak
rapid
induct
immun
induc
mlv
vaccin
clinic
advantag
infect
take
day
sign
diseas
appear
vomit
usual
develop
day
onset
fever
diarrhoea
may
begin
later
alway
present
dehydr
develop
rapidli
affect
cat
may
sit
water
bowl
obvious
thirsti
without
drink
termin
case
hypotherm
may
develop
septic
shock
dissemin
intravascular
coagul
environ
viru
remain
infecti
one
year
therefor
facil
infect
anim
present
must
consid
infect
fact
sheet
felin
herpesviru
vaccin
prepar
contain
margin
attenu
felin
herpesviru
felin
rhinotrach
viru
occur
singl
serotyp
variou
titr
without
adjuv
inject
prepar
other
intranas
applic
alon
combin
vaccin
antigen
alway
felin
caliciviru
adjuv
kill
subunit
vaccin
develop
assess
doi
difficult
complet
clinic
protect
seen
shortli
vaccin
efficaci
decreas
time
immun
far
solid
natur
infectiondiseas
variabl
durat
protect
afford
well
felin
caliciviru
vaccin
complet
seen
felin
panleukopenia
vaccin
two
felin
core
vaccin
fcv
expect
provid
robust
degre
durat
immun
seen
canin
core
vaccin
fpv
persist
antibodi
titr
vaccin
kill
vaccin
demonstr
year
antibodi
titr
correl
protect
protect
challeng
virul
year
vaccin
two
dose
kill
vaccin
complet
similar
protect
year
kill
product
complet
kitten
seri
around
week
vaccin
year
age
revaccin
need
done
often
everi
year
booster
vaccin
laps
singl
inject
consid
adequ
boost
immunolog
memori
herpesviru
vaccin
protect
infect
virul
viru
becom
latent
may
reactiv
period
sever
stress
reactiv
viru
may
caus
clinic
sign
vaccin
anim
viru
may
shed
transmit
suscept
anim
caus
diseas
suscept
kitten
cat
cellmedi
immun
play
import
role
protect
sinc
absenc
detect
serum
antibodi
level
vaccin
cat
necessarili
indic
cat
suscept
diseas
hand
seroconvers
correl
protect
virul
challeng
mda
interfer
activ
immun
vari
period
time
kitten
depend
titr
colostr
antibodi
amount
antibodi
absorb
birth
primari
cours
vaccin
usual
start
around
week
age
although
vaccin
licens
use
earlier
age
mda
interfer
less
mlv
intranas
vaccin
parenter
administ
mlv
product
would
expect
vaccin
immun
week
earlier
parenter
vaccin
kitten
mda
modifi
live
parenter
vaccin
retain
pathogen
potenti
may
induc
diseas
administ
incorrectli
ie
accident
aerosol
ingest
vaccin
deposit
skinhair
upper
respiratori
diseas
sign
sometim
seen
follow
intranas
vaccin
breed
catteri
infect
mostli
appear
kitten
prior
wean
typic
week
age
mda
wane
case
sourc
infect
queen
whose
latent
viru
reactiv
due
stress
parturit
lactat
viral
excret
start
soon
hour
infect
last
week
acut
diseas
appear
day
resolv
within
day
viru
spread
along
sensori
nerv
reach
neuron
particularli
trigemin
ganglia
main
site
latenc
cat
becom
lifelong
latent
carrier
shed
viru
period
upon
stress
event
viral
genom
dna
persist
nucleu
infect
neuron
without
replic
environ
viru
labil
inactiv
common
disinfect
prepar
contain
felin
calicivirus
sever
type
without
adjuv
inject
prepar
other
intranas
applic
alon
combin
vaccin
antigen
alway
felin
herpesviru
kill
adjuv
vaccin
also
avail
consider
antigen
variabl
amongst
fcv
strain
viru
consid
singl
serotyp
prior
infect
one
strain
significantli
reduc
acut
clinic
sign
upon
exposur
heterolog
strain
also
oral
viru
shed
gener
level
heterolog
protect
depend
pair
viru
strain
examin
viru
neutral
antibodi
first
appear
approxim
day
infect
titr
correl
well
protect
homolog
challeng
cat
may
also
protect
absenc
serum
antibodi
sinc
local
secretori
iga
antibodi
cellular
respons
demonstr
provid
protect
vaccin
cat
vaccin
kill
fcv
vaccin
antibodi
shown
persist
year
accordingli
doi
year
establish
fcv
vaccin
protect
challeng
virul
fcv
year
vaccin
two
dose
kill
vaccin
complet
similar
protect
year
kill
product
protect
afford
fcv
well
felin
herpesviru
vaccin
complet
seen
felin
panleukopenia
vaccin
two
core
respiratori
vaccin
expect
provid
robust
degre
durat
immun
seen
felin
parvoviru
canin
core
vaccin
complet
kitten
seri
around
week
vaccin
year
age
revaccin
need
done
often
everi
year
mda
import
protect
first
week
life
may
interfer
vaccin
averag
halflif
mda
determin
day
persist
week
field
studi
kitten
six
week
age
detect
antibodi
wide
use
vaccin
strain
mda
interfer
less
mlv
intranas
parenter
administ
mlv
product
would
expect
vaccin
immun
week
earlier
parenter
vaccin
kitten
mda
upper
respiratori
diseas
sign
commonli
seen
follow
intranas
vaccin
multitud
antigen
differ
virus
circul
field
vaccin
strain
combin
chosen
crossprotect
sever
clinic
diseas
mild
diseas
may
still
occur
vaccin
cat
contrast
felin
herpesviru
shed
upon
stress
event
shed
fcv
continu
impact
vaccin
shed
controversi
observ
rang
moder
reduct
extens
period
viru
shed
post
infect
live
parenter
fcv
vaccin
strain
shed
although
infrequ
fcv
infect
caus
acut
oral
upper
respiratori
sign
also
associ
chronic
gingivostomat
may
immunemedi
acut
oral
upper
respiratori
diseas
sign
mainli
seen
kitten
incub
period
day
oral
ulcer
sneez
serou
nasal
discharg
main
sign
recent
new
syndrom
virul
system
felin
caliciviru
vsfcv
diseas
describ
incub
period
infect
cat
expos
shelter
hospit
day
home
environ
may
day
diseas
appear
sever
adult
kitten
vaccin
current
vaccin
protect
cat
field
infect
protect
shown
experiment
might
due
either
inher
characterist
hypervirul
strain
fact
vaccin
suscept
strain
unlik
caus
outbreak
sinc
vaccin
wide
practic
kill
vsfcv
strain
vaccin
avail
usa
report
provid
protect
vsfcv
strain
known
strain
vsfcv
provid
protect
homolog
heterolog
vsfcv
strain
use
worldwid
oral
immun
wildlif
eg
fox
canada
europ
raccoon
dog
finland
safe
deriv
sad
street
alabama
dufferin
viru
strain
recombin
vaccin
virus
particularli
safe
contain
singl
rabi
viru
gene
glycoprotein
g
relev
protect
poxvirus
vaccinia
canari
pox
vector
express
rabi
viru
glycoprotein
use
routin
usa
control
rabi
wildlif
vaccinia
vector
oral
rout
cat
canari
pox
vector
parenter
rout
vaccin
avail
use
year
usa
vaccin
avirul
avian
mammalian
speci
test
use
kill
vaccin
rule
individu
dog
cat
protect
mass
canin
vaccin
kill
vaccin
easier
manag
live
prepar
stabil
ambient
temperatur
accid
selfinocul
repres
risk
would
case
mlv
vaccin
canin
felin
rabi
control
mostli
use
inactiv
vaccin
howev
usa
recombin
canari
pox
vector
rabi
vaccin
licens
wide
use
cat
associ
pronounc
inflamm
inject
site
caus
adjuv
rabi
vaccin
recombin
canari
pox
vaccin
licens
use
dog
current
formul
provid
immun
dog
cat
gener
respond
better
dog
rabi
vaccin
usa
initi
rabi
vaccin
must
follow
one
year
later
revaccin
second
vaccin
interv
revaccin
legal
extend
year
product
year
doi
label
doi
natur
infect
assess
diseas
follow
street
viru
infect
fatal
dog
cat
doi
vaccin
commerci
avail
inactiv
recombin
product
year
longer
base
challeng
serolog
studi
first
vaccin
earlier
week
age
revaccin
one
year
later
antibodi
titr
gener
achiev
protect
level
week
inject
serolog
test
requir
legal
purpos
interv
vaccin
test
crucial
may
productdepend
product
data
sheet
legal
requir
consult
vaccin
protect
virul
rabi
viru
challeng
year
longer
nation
local
legisl
may
call
annual
booster
vgg
encourag
legisl
consid
scientif
advanc
formul
polici
presenc
serum
antibodi
titr
iuml
activ
immun
dog
age
week
correl
protect
achiev
titr
iuml
also
consid
legal
requir
pet
travel
countri
includ
serolog
test
postvaccin
protocol
movement
pet
sign
diseas
appear
week
sever
month
infect
depend
upon
site
infect
transmiss
gener
bite
scratch
unexplain
aggress
behaviour
sudden
behaviour
chang
must
consid
suspici
diseas
manifest
furiou
dumb
form
sign
classic
furiou
form
rabi
includ
reduc
palpebr
corneal
pupillari
reflex
strabismu
drop
jaw
saliv
seizur
twitch
tremor
disorient
aimless
pace
exagger
emot
respons
irrit
rage
fear
photophobia
well
ataxia
paralysi
ultim
follow
coma
death
respiratori
arrest
dumb
form
rabi
common
dog
cat
present
lower
motor
neuron
paralysi
progress
site
bite
injuri
involv
entir
central
nervou
system
paralysi
rapidli
lead
coma
death
respiratori
failur
environ
viru
quickli
loos
infect
readili
inactiv
use
detergentbas
disinfect
question
relat
vaccin
product
may
give
mlv
product
wild
exot
speci
domest
speci
one
vaccin
licens
protect
never
give
mlv
vaccin
unless
shown
safe
speci
mani
mlv
vaccin
caus
diseas
anim
speci
licens
even
wors
vaccin
could
shed
wild
anim
regain
virul
multipl
passag
caus
diseas
even
target
speci
develop
consequ
could
catastroph
highli
effect
safe
vaccin
speci
suscept
cdv
canari
poxvirusvector
recombin
cdv
vaccin
avail
monoval
product
ferret
combin
product
dog
monoval
vaccin
use
mani
wild
exot
speci
suscept
cdv
avail
certain
countri
due
insuffici
amount
viru
human
mv
vaccin
immunogen
puppi
measl
viru
vaccin
made
specif
dog
sometim
combin
cdv
addit
viral
compon
give
temporari
protect
earlier
age
cdv
vaccin
week
older
puppi
must
vaccin
cdv
vaccin
achiev
perman
immun
certain
vaccin
immun
pup
matern
deriv
antibodi
mda
cdv
earlier
age
convent
mlv
cdv
vaccin
ye
heterotyp
measl
vaccin
dog
immun
pup
week
earlier
mlvcdv
vaccin
similarli
canari
pox
vector
recombin
cdv
vaccin
immun
approxim
week
earlier
mlv
vaccin
ye
mda
inde
block
certain
kill
vaccin
kill
product
requir
two
dose
often
case
first
dose
block
mda
second
dose
immun
circumst
second
dose
prime
block
third
dose
requir
immun
boost
true
mlv
absenc
mda
take
singl
dose
prime
immun
boost
nevertheless
two
dose
often
recommend
particularli
young
anim
sure
one
given
mda
block
puppi
kitten
seri
last
dose
given
around
week
age
later
vgg
awar
certain
canin
vaccin
licens
earli
finish
order
allow
pup
benefit
earli
social
vgg
accept
behaviour
benefit
practic
reserv
immunolog
valid
combin
core
product
current
avail
immun
accept
percentag
puppi
last
dose
given
week
age
vgg
advis
wherev
possibl
last
dose
given
around
week
age
regardless
number
dose
given
earlier
earli
finish
protocol
adopt
vgg
recommend
owner
care
control
exposur
pup
restrict
environ
permit
contact
healthi
fulli
vaccin
puppi
may
give
type
vaccin
parenter
intranas
exampl
canin
felin
vaccin
use
prevent
respiratori
diseas
kennel
cough
felin
upper
respiratori
diseas
ye
howev
sure
give
product
approv
rout
use
parenter
mlv
vaccin
contain
fcv
local
could
caus
diseas
cat
use
kill
fcv
vaccin
local
would
get
immun
might
caus
signific
advers
reaction
gave
intranas
live
kennel
cough
vaccin
parenter
could
caus
sever
necrot
local
reaction
even
kill
dog
wherea
give
parenter
kill
bordetella
vaccin
intranas
immun
may
caus
hypersensit
reaction
howev
type
product
given
time
variou
time
life
anim
vaccin
parenter
intranas
may
actual
provid
better
immun
vaccin
one
site
thu
parenter
vaccin
provid
protect
lung
littl
immun
upper
respiratori
tract
especi
local
secretori
iga
cmi
wherea
intranas
vaccin
engend
good
secretori
iga
local
cmi
nonspecif
immun
eg
type
interferon
alway
provid
immun
lung
long
vaccin
take
dog
develop
immun
prevent
sever
diseas
core
vaccin
use
depend
anim
vaccin
diseas
fastest
immun
provid
cdv
vaccin
mlv
recombin
canari
pox
viru
vector
immun
respons
start
within
minut
hour
provid
protect
within
day
anim
without
interf
level
mda
dog
sever
immunosuppress
immun
fpv
develop
day
usual
present
day
effect
mlv
vaccin
use
contrast
kill
fpv
vaccin
often
take
week
longer
provid
protect
immun
mlv
given
parenter
would
provid
immun
day
howev
given
intranas
level
immun
present
week
dog
nt
develop
thu
parenter
recommend
immun
time
vaccin
immun
difficult
determin
fcv
anim
develop
protect
immun
howev
develop
take
day
dog
properli
vaccin
mlv
recombin
cdv
would
protect
diseas
similarli
would
expect
high
protect
infect
properli
vaccin
cat
receiv
mlv
vaccin
would
estim
would
protect
diseas
infect
fpv
contrast
expect
fcv
vaccin
best
protect
diseas
infect
especi
highli
contamin
environ
eg
shelter
protect
would
seen
high
risk
environ
protect
would
appear
much
higher
household
pet
cat
isol
cat
cat
vaccin
household
long
time
risk
infect
virus
much
lower
stress
level
mutant
biotyp
variant
cdv
field
current
vaccin
provid
protect
immun
current
cdv
vaccin
provid
protect
known
isol
cdv
respect
test
experiment
well
field
ye
vaccin
regardless
variant
contain
stimul
activ
immun
respons
eg
antibodi
respons
provid
long
term
year
protect
current
variant
dog
challeng
fpv
vaccin
given
oral
immun
immun
given
intranas
howev
effect
rout
parenter
subcutan
intramuscular
vaccin
revaccin
often
everi
year
necessari
annual
revaccin
increas
develop
inject
site
sarcoma
adjuv
vaccin
use
avail
vaccin
gener
determin
manufactur
local
region
licens
author
basi
scientif
knowledg
pertain
local
diseas
situat
market
consider
current
fiv
vaccin
contain
two
clade
subtyp
fiv
although
crossprotect
clade
claim
geograph
differ
clade
viru
circul
particular
countri
also
remain
issu
potenti
vaccin
interfer
serodiagnost
test
fiv
infect
cat
given
fiv
vaccin
test
serum
antibodi
vaccin
identifi
microchip
ye
vaccin
prevent
infect
latenc
subtyp
fiv
thu
fiv
vaccin
cat
also
infect
act
sourc
viru
suscept
cat
race
greyhound
found
infect
develop
diseas
routin
vaccin
time
year
commerci
kennel
cough
vaccin
civ
antigen
unrel
viru
dog
relat
equin
influenza
viru
new
civ
vaccin
condit
licens
usa
recommend
atrisk
dog
ye
new
vaccin
recent
licens
condit
usa
design
aid
prevent
influenza
dog
caus
viru
product
adjuv
kill
vaccin
like
kill
vaccin
requir
two
initi
dose
given
week
apart
efficaci
durat
immun
civ
vaccin
other
may
develop
futur
determin
next
year
inform
accumul
field
ye
vaccin
use
prevent
concept
aid
prevent
death
snakebit
certain
speci
snake
aid
prevent
treatment
periodont
diseas
aid
treatment
melanoma
dog
furthermor
addit
canin
felin
vaccin
develop
design
prevent
infecti
diseas
nosod
use
prevent
diseas
immun
contain
antigen
one
never
mix
differ
vaccin
prepar
syring
unless
specifi
data
sheet
ye
howev
differ
vaccin
inject
separ
site
drain
differ
lymph
node
volum
eg
ml
recommend
manufactur
gener
repres
minimum
immun
dose
therefor
total
amount
must
given
ye
unlik
pharmaceut
dosedepend
vaccin
base
volum
per
bodi
mass
size
rather
minimum
immun
dose
best
possibl
patient
may
develop
hypersensit
reaction
vomit
lead
increas
risk
aspir
also
anaesthet
agent
may
immunomodulatori
vaccin
mlv
kill
product
pregnanc
avoid
possibl
except
especi
shelter
vaccin
would
advis
pregnant
anim
never
vaccin
outbreak
diseas
eg
cdv
fpv
studi
speci
suggest
immunosuppress
glucocorticoid
treatment
prior
concurr
vaccin
signific
suppress
affect
antibodi
product
vaccin
howev
revaccin
recommend
sever
week
glucocorticotherapi
therapi
end
especi
treatment
occur
administr
initi
seri
core
vaccin
vaccin
especi
mlv
product
avoid
may
caus
diseas
vaccin
kill
product
may
effect
may
aggrav
immunemedi
diseas
minimum
week
vaccin
given
often
everi
week
even
differ
vaccin
given
last
dose
vaccin
given
week
age
older
kill
vaccin
may
induc
effect
antibodi
respons
neutral
mlv
vaccin
therebi
prevent
immun
would
prefer
give
mlv
vaccin
first
ifwhen
need
revaccin
kill
vaccin
prepar
vaccin
caus
sever
local
reaction
may
even
kill
pet
caus
system
diseas
eg
liver
failur
stimul
protect
respons
bordetella
may
caus
hypersensit
respons
give
live
vaccin
via
intranas
rout
specifi
data
sheet
ye
mucos
eg
conjunctiv
nasal
contact
prepar
must
avoid
vaccin
viru
caus
diseas
ye
may
even
desir
use
vaccin
differ
manufactur
life
anim
differ
product
may
contain
differ
strain
eg
felin
caliciviru
disinfect
might
inactiv
mlv
product
known
provid
benefit
ye
exampl
leptospira
bacterin
often
use
diluent
viral
antigen
combin
viral
cake
may
resuspend
steril
water
buffer
salin
leptospira
bacterin
given
separ
anoth
site
time
discard
ye
one
dose
mlv
canin
core
vaccin
cdv
felin
core
vaccin
fpv
fcv
provid
long
term
immun
given
anim
week
age
everi
puppi
kitten
week
age
older
must
receiv
least
one
dose
mlv
core
vaccin
done
herd
popul
immun
would
significantli
improv
even
usa
good
vaccin
record
probabl
puppi
kitten
ever
receiv
vaccin
must
vaccin
anim
popul
core
vaccin
achiev
herd
immun
eg
higher
prevent
epidem
outbreak
anim
first
receiv
vaccin
requir
two
dose
immun
eg
kill
vaccin
like
leptospira
bacterin
felin
leukemia
viru
return
second
dose
within
week
immun
singl
dose
twodos
vaccin
provid
immun
first
dose
prime
immun
system
second
immun
second
dose
given
within
week
first
regim
start
make
sure
two
dose
given
within
week
two
dose
revaccin
singl
dose
done
yearli
greater
interv
boost
respons
room
temperatur
sensit
vaccin
eg
cdv
lose
abil
immun
hour
wherea
compon
remain
immunogen
sever
day
eg
cpv
fpv
vgg
recommend
mlv
vaccin
reconstitut
use
within
hr
anim
gone
beyond
time
gener
consid
minimum
doi
core
vaccin
year
cdv
year
fpv
fcv
start
seri
vaccin
multipl
dose
week
apart
mlv
vaccin
multipl
dose
requir
puppi
kitten
age
anim
mda
vgg
awar
mani
data
sheet
advis
restart
vaccin
seri
endors
practic
inconsist
fundament
immun
system
function
principl
immunolog
memori
felv
fiv
posit
cat
clinic
well
would
ideal
hous
indoor
away
cat
minim
risk
exposur
infecti
diseas
howev
deem
necessari
vaccin
core
compon
fpv
fcv
kill
mlv
vaccin
cat
vaccin
felv
fiv
felv
fiv
posit
cat
clinic
ill
vaccin
countri
legal
requir
rabi
vaccin
would
also
includ
infect
cat
felin
vaccin
particularli
adjuv
product
given
interscapular
region
usa
practic
give
separ
inject
rabi
vaccin
distal
right
hind
limb
felv
vaccin
distal
left
hind
limb
practic
altern
site
subcutan
inject
later
thorac
abdomin
wall
abdomin
wall
repres
site
inject
site
sarcoma
readili
resect
surgic
site
recommend
vgg
whichev
site
chosen
vaccin
must
administ
subcutan
intramuscularli
importantli
anatom
site
felin
vaccin
rotat
vaccin
given
repeatedli
one
locat
may
achiev
record
site
vaccin
individu
occas
rotat
adopt
practic
polici
use
one
anatom
locat
year
ye
shown
certain
sever
defici
vitamin
trace
miner
eg
vitamin
ese
interfer
develop
protect
immun
respons
puppi
known
suspect
nutrit
defici
correct
appropri
nutrit
supplement
anim
revaccin
ensur
adequ
protect
immun
puppi
kitten
fail
receiv
colostrum
passiv
antibodi
protect
dam
depend
antibodi
titr
dam
littl
like
protect
approxim
passiv
antibodi
newborn
puppi
kitten
obtain
colostrum
absorb
via
intestin
system
circul
hour
birth
journal
small
anim
practic
vol
june
wsava
puppi
kitten
fail
receiv
colostrum
vaccin
first
week
life
sinc
matern
deriv
antibodi
block
activ
immun
puppi
kitten
less
week
age
vaccin
mlv
core
vaccin
certain
modifi
live
vaccin
virus
given
pupskitten
less
week
age
without
mda
infect
central
nervou
system
andor
caus
diseas
possibl
death
anim
occur
littl
thermoregulatori
control
bodi
temperatur
first
week
birth
thu
innat
adapt
immun
significantli
impair
colostrumdepriv
young
anim
protect
core
diseas
artifici
colostrum
fed
puppi
kitten
less
day
old
never
fed
protein
diet
artifici
colostrum
ac
milk
replac
eg
esbilac
tm
similar
product
immun
serum
prefer
dam
well
vaccin
anim
live
environ
dam
pup
kitten
receiv
protein
eg
milk
replac
oral
day
age
older
serum
well
immun
adult
anim
given
subcutan
intraperiton
citrat
plasma
given
intraven
depend
size
anim
approxim
ml
serum
plasma
administ
twice
daili
day
risk
overvaccin
pet
eg
inject
often
use
vaccin
requir
specif
pet
ye
vaccin
given
needlessli
may
caus
advers
reaction
vaccin
medic
product
tailor
need
individu
anim
also
administ
bacterin
advis
give
separ
time
rather
give
togeth
ye
although
develop
advers
reaction
often
depend
genet
anim
eg
small
breed
dog
famili
dog
certain
vaccin
higher
likelihood
produc
advers
reaction
especi
reaction
caus
type
hypersensit
exampl
bacterin
kill
bacteri
vaccin
leptospira
bordetella
borrelia
chlamydophila
like
caus
advers
reaction
mlv
viral
vaccin
vaccin
suggest
caus
advers
reaction
core
vaccin
serolog
test
perform
anim
found
seroposit
antibodi
cdv
fpv
revaccin
necessari
vaccin
option
noncor
vaccin
eg
leptospira
bordetella
bacterin
revaccin
discourag
rabi
local
author
must
consult
determin
whether
rabi
vaccin
administ
law
whether
antibodi
titr
may
determin
altern
vaccin
absolut
necessari
switch
product
manufactur
may
help
hypersensit
reaction
known
relat
excipi
contain
within
vaccin
eg
trace
bovin
serum
albumin
use
viru
cultur
process
use
antihistamin
prerevaccin
accept
interfer
vaccin
immun
respons
revaccin
suscept
anim
close
monitor
hour
postvaccin
although
reaction
type
hypersensit
gener
occur
within
minut
exposur
type
hypersensit
ii
iii
iv
occur
much
later
eg
hour
month
vaccin
caus
autoimmun
diseas
genet
predispos
anim
may
trigger
autoimmun
respons
follow
diseas
infect
drug
varieti
environment
factor
definit
answer
question
difficult
obtain
accur
data
determin
frequenc
advers
reaction
reli
upon
veterinarian
owner
report
reaction
manufactur
nation
author
rout
exist
current
accept
vaccin
use
safe
low
incid
possibl
side
effect
benefit
protect
seriou
infecti
diseas
far
outweigh
risk
develop
advers
reaction
recent
analysi
major
us
hospit
group
databas
allow
public
data
base
larg
number
vaccin
dog
cat
advers
reaction
kind
includ
minor
reaction
document
within
first
day
follow
vaccin
vaccin
dog
advers
reaction
kind
includ
minor
reaction
document
within
first
day
